PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Change in WHO recommendations for standard of care (control arm); availability of new shorter treatment regimens for MDR-TB; war in Ukraine where two study sites are located; key trial team members left the team.

Conditions

Tuberculosis, Pulmonary
Tuberculosis, Multidrug-Resistant
Bacterial Infections
Mycobacterial Infection

Interventions

DIAGNOSTIC_TEST: Individualised treatment duration based on RNA transcriptomic model

Sponsor

Research Center Borstel

Collaborators

[object Object]